Comparison of the Efficacy and Safety of Biosimilar Adalimumab Injection with Innovator Adalimumab in Subjects with Active Ankylosing Spondylitis
Journal of The Association of Physicians of India · 2025
DOI: 10.59556/japi.73.1117 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of The Association of Physicians of India, 2025. Verfasst von S Chandrashekara und 24 weiteren Autor:innen. Beteiligte Einrichtung: Managing Director, Department of Rheumatology, ChanRe Rheumatology and Immunology Center and Research, Bengaluru, Karnataka, India, Orcid: https://or…. Hauptthemen laut MEDLINE: Adalimumab, Biosimilar Pharmaceuticals, Spondylitis, Ankylosing, Antirheumatic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Managing Director, Department of Rheumatology, ChanRe Rheumatology and Immunology Center and Research, Bengaluru, Karnataka, India, Orcid: https://orcid.org/0000-0003-2661-9840, Corresponding Author.
- Odisha Arthritis and Rheumatology Center, Bhubaneswar, Odisha, India.
- Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India, Orcid: https://orcid.org/0000-0002-5717-0559.
- Avron Hospitals Pvt. Ltd., Ahmedabad, Gujarat, India, Orcid: https://orcid.org/0009-0005-2741-2472.
- Medical College and Hospital, Kolkata, West Bengal, India, Orcid: https://orcid.org/0009-0006-7007-5536.
- Christian Medical College, Vellore, Tamil Nadu, India, Orcid: https://orcid.org/0000-0002-9857-2271.
Zitieren
APA
Chandrashekara, S., Parida, J. R., Sonawale, A., Sharma, V., Basu, K., Mathew, J., Dharmapalaiah, C., Seth, G., Kakade, G., Jain, N., Sharma, R., Fatima, F., Srivastava, R. N., Shah, R., Desai, B., Nalawade, A., Haridas, V., Kumar, U., Naidu, A. R., …, & Pawar, D. (2025). Comparison of the Efficacy and Safety of Biosimilar Adalimumab Injection with Innovator Adalimumab in Subjects with Active Ankylosing Spondylitis. Journal of The Association of Physicians of India. https://doi.org/10.59556/japi.73.1117
Vancouver
Chandrashekara S, Parida JR, Sonawale A, Sharma V, Basu K, Mathew J, et al. Comparison of the Efficacy and Safety of Biosimilar Adalimumab Injection with Innovator Adalimumab in Subjects with Active Ankylosing Spondylitis. Journal of The Association of Physicians of India. 2025. doi:10.59556/japi.73.1117
BibTeX
@article{Chandrashekara2025,
author = {Chandrashekara, S and Parida, Jyoti Ranjan and Sonawale, Archana and Sharma, Vishnu and Basu, Kaushik and Mathew, John and Dharmapalaiah, Chethana and Seth, Gaurav and Kakade, Girish and Jain, Neeraj and Sharma, Reena and Fatima, Firdaus and Srivastava, Rajeshwar Nath and Shah, Romi and Desai, Bankim and Nalawade, Ajit and Haridas, Vikram and Kumar, Uma and Naidu, A Ramakrishnam and Pawar, Roshan and Aiwale, Amol and Rane, Yogesh and Shahavi, Vinayaka and Sharma, Akhilesh and Pawar, Dattatreya},
title = {Comparison of the Efficacy and Safety of Biosimilar Adalimumab Injection with Innovator Adalimumab in Subjects with Active Ankylosing Spondylitis},
journal = {Journal of The Association of Physicians of India},
year = {2025},
doi = {10.59556/japi.73.1117}
}
EUVIMED